Intravenous iron exposure and outcomes in patients on hemodialysis.
作者信息
Fishbane Steven, Mathew Anna T, Wanchoo Rimda
机构信息
Department of Medicine, Division of Nephrology, Hofstra North Shore-LIJ Medical Center, Great Neck, New York
Department of Medicine, Division of Nephrology, Hofstra North Shore-LIJ Medical Center, Great Neck, New York.
出版信息
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1837-9. doi: 10.2215/CJN.09510914. Epub 2014 Oct 15.
Abstract
摘要
相似文献
1
Intravenous iron exposure and outcomes in patients on hemodialysis.血液透析患者静脉铁暴露与结局
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1837-9. doi: 10.2215/CJN.09510914. Epub 2014 Oct 15.
2
Intravenous iron exposure and mortality in patients on hemodialysis.血液透析患者静脉铁暴露与死亡率
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1930-9. doi: 10.2215/CJN.03370414. Epub 2014 Oct 15.
3
Anemia management and mortality risk in incident hemodialysis patients.
JAMA. 2010 Jul 7;304(1):41-2; author reply 42-3. doi: 10.1001/jama.2010.890.
4
Intravenous iron dose and mortality in hemodialysis patients.
Kidney Int. 2015 Jun;87(6):1261-2. doi: 10.1038/ki.2015.82.
5
Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients.血液透析患者推注与维持铁补充的感染风险。
J Am Soc Nephrol. 2013 Jun;24(7):1151-8. doi: 10.1681/ASN.2012121164. Epub 2013 Jun 20.
6
Urgent: Stop Preventable Infections Now.紧急：立即阻止可预防的感染。
Clin J Am Soc Nephrol. 2018 Apr 6;13(4):663-665. doi: 10.2215/CJN.10790917. Epub 2018 Mar 22.
7
Safety of intravenous iron in hemodialysis patients.血液透析患者静脉补铁的安全性
Hemodial Int. 2017 Jun;21 Suppl 1(Suppl 1):S93-S103. doi: 10.1111/hdi.12558. Epub 2017 Apr 3.
8
Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients.血液透析患者静脉补铁治疗实践与心血管事件短期风险
PLoS One. 2013 Nov 1;8(11):e78930. doi: 10.1371/journal.pone.0078930. eCollection 2013.
9
Impact of Transferrin Saturation on All-Cause Mortality in Patients on Maintenance Hemodialysis.转铁蛋白饱和度对维持性血液透析患者全因死亡率的影响。
Blood Purif. 2019;48(2):158-166. doi: 10.1159/000499758. Epub 2019 Jul 16.
10
Hemodialysis: Long weekend hemodialysis intervals--killing fields?
Nat Rev Nephrol. 2011 Nov 22;8(1):5-6. doi: 10.1038/nrneph.2011.192.
引用本文的文献
1
Serum ferritin and neutrophil-to-lymphocyte ratio predict all-cause mortality in patients receiving maintenance hemodialysis: a prospective study.血清铁蛋白和中性粒细胞与淋巴细胞比值可预测维持性血液透析患者的全因死亡率：一项前瞻性研究。
Front Mol Biosci. 2024 Feb 29;11:1366753. doi: 10.3389/fmolb.2024.1366753. eCollection 2024.
2
Trends in the treatment of chronic kidney disease-associated anaemia in a cohort of haemodialysis patients: the Irish experience.一组血液透析患者慢性肾脏病相关性贫血的治疗趋势：爱尔兰的经验
Ir J Med Sci. 2019 Feb;188(1):223-230. doi: 10.1007/s11845-018-1823-0. Epub 2018 Apr 27.
3
Comparison of Methods Study between a Photonic Crystal Biosensor and Certified ELISA to Measure Biomarkers of Iron Deficiency in Chronic Kidney Disease Patients.比较光子晶体生物传感器和认证 ELISA 方法在测量慢性肾脏病患者缺铁生物标志物中的应用。
Sensors (Basel). 2017 Sep 25;17(10):2203. doi: 10.3390/s17102203.
4
Serum Ferritin Variations and Mortality in Incident Hemodialysis Patients.血清铁蛋白变化与新进入血液透析患者的死亡率。
Am J Nephrol. 2017;46(2):120-130. doi: 10.1159/000478735. Epub 2017 Jul 14.
5
Longitudinal trends in serum ferritin levels and associated factors in a national incident hemodialysis cohort.全国新发血液透析队列中血清铁蛋白水平的纵向趋势及相关因素
Nephrol Dial Transplant. 2017 Feb 1;32(2):370-377. doi: 10.1093/ndt/gfw012.
6
Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients.通过透析液给予柠檬酸铁焦磷酸盐可减少血液透析患者促红细胞生成素的使用并维持血红蛋白水平。
Kidney Int. 2015 Nov;88(5):1187-94. doi: 10.1038/ki.2015.203. Epub 2015 Jul 8.
7
The Labile Side of Iron Supplementation in CKD.慢性肾脏病中铁补充治疗的不稳定方面
J Am Soc Nephrol. 2015 Nov;26(11):2612-9. doi: 10.1681/ASN.2015010052. Epub 2015 May 21.
本文引用的文献
1
Intravenous iron exposure and mortality in patients on hemodialysis.血液透析患者静脉铁暴露与死亡率
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1930-9. doi: 10.2215/CJN.03370414. Epub 2014 Oct 15.
2
Iron increases diabetes-induced kidney injury and oxidative stress in rats.铁会加重糖尿病诱导的大鼠肾损伤及氧化应激。
Biol Trace Elem Res. 2014 Sep;160(3):368-75. doi: 10.1007/s12011-014-0021-9. Epub 2014 Jul 6.
3
4
Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients.血液透析患者推注与维持铁补充的感染风险。
J Am Soc Nephrol. 2013 Jun;24(7):1151-8. doi: 10.1681/ASN.2012121164. Epub 2013 Jun 20.
5
Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients.静脉注射六水合氯化铁补充剂可导致血液透析患者的内皮功能障碍和心血管风险增加。
PLoS One. 2012;7(12):e50295. doi: 10.1371/journal.pone.0050295. Epub 2012 Dec 5.
6
Pumping iron: revisiting risks, benefits and strategies in treatment of iron deficiency in end-stage renal disease.补铁：重新审视终末期肾病缺铁治疗中的风险、益处及策略
Clin Nephrol. 2012 Mar;77(3):188-94. doi: 10.5414/cn107266.
7
Hepcidin and iron regulation, 10 years later.十年后的铁调素与铁稳态调控
Blood. 2011 Apr 28;117(17):4425-33. doi: 10.1182/blood-2011-01-258467. Epub 2011 Feb 23.
8
Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.葡萄糖酸铁对血清铁蛋白高且转铁蛋白饱和度低的贫血血液透析患者疗效显著：铁蛋白升高时静脉注射铁剂的透析患者反应（DRIVE）研究结果
J Am Soc Nephrol. 2007 Mar;18(3):975-84. doi: 10.1681/ASN.2006091034. Epub 2007 Jan 31.
9
Time-dependent associations between iron and mortality in hemodialysis patients.血液透析患者中铁与死亡率之间的时间依赖性关联。
J Am Soc Nephrol. 2005 Oct;16(10):3070-80. doi: 10.1681/ASN.2005040423. Epub 2005 Jul 20.
10
Administration of parenteral iron and mortality among hemodialysis patients.胃肠外铁剂给药与血液透析患者的死亡率
J Am Soc Nephrol. 2004 Jun;15(6):1623-32. doi: 10.1097/01.asn.0000128009.69594.be.
Zotero 插件